Research team clarifies the mechanism of gliotoxin, a mycotoxin from the
fungus Aspergillus fumigatus
By Ute Schönfelder, Friedrich Schiller UniversitatJena
February 7, 2019 --It is everywhere – and it is extremely dangerous for people with a weakened immune system. The fungus Aspergillus fumigatus occurs virtually everywhere on Earth, as a dark grey, wrinkled cushion on damp walls or in microscopically small spores that blow through the air and cling to wallpaper, mattresses and floors.
Healthy people usually have no problem if spores find their way into their body, as their immune defence system will put the spores out of action. However, the fungus can threaten the lives of people with a compromised immune system, such as AIDS patients or people who are immunosuppressed following an organ transplantation.
An international research team led by Prof. Oliver Werz ofFriedrich Schiller University ,
Jena , has now
discovered how the fungus knocks out the immune defences, enabling a
potentially fatal fungal infection to develop. The researchers present their
findings in the current issue of the specialist journal Cell Chemical Biology (DOI: 10.1016/j.chembiol.2019.01.001).
Among other factors, it is gliotoxin – a potent mycotoxin – that is responsible for the pathogenicity of Aspergillus fumigatus. "It was known," says study manager Werz of theInstitute of Pharmacy at the University of Jena ,
"that this substance has an immunosuppressive effect, which means that
it weakens the activity of cells of the immune defence system."
However, it had not been clear previously how exactly this happens. Werz and
his team colleagues have now studied this in detail and have clarified the
underlying molecular mechanisms.
By Ute Schönfelder, Friedrich Schiller Universitat
February 7, 2019 --It is everywhere – and it is extremely dangerous for people with a weakened immune system. The fungus Aspergillus fumigatus occurs virtually everywhere on Earth, as a dark grey, wrinkled cushion on damp walls or in microscopically small spores that blow through the air and cling to wallpaper, mattresses and floors.
Healthy people usually have no problem if spores find their way into their body, as their immune defence system will put the spores out of action. However, the fungus can threaten the lives of people with a compromised immune system, such as AIDS patients or people who are immunosuppressed following an organ transplantation.
An international research team led by Prof. Oliver Werz of
Among other factors, it is gliotoxin – a potent mycotoxin – that is responsible for the pathogenicity of Aspergillus fumigatus. "It was known," says study manager Werz of the
Immune Cells Communicate with One Another
To achieve this,
the researchers brought immune cells into contact with synthetically produced
gliotoxin. These cells, called neutrophilic granulocytes, represent the first
line of the immune defence system. "Their task is to detect pathogens
and eliminate them," explains Werz. As soon as such a cell comes into
contact with a pathogen, for example a fungus, it releases specific messenger
substances (leukotrienes) into the blood, which attract other immune cells.
Once a sufficiently large number of immune cells has gathered, they can render
the intruder harmless.
Mycotoxin Switches Off Enzyme
This does not
happen if the pathogen Aspergillus fumigatus is involved. As the Jena scientists were able
to show, gliotoxin ensures that production of the messenger substance
leukotrieneB4 in the neutrophilic granulocytes is inhibited, so that they are
unable to send a signal to other immune cells. This is caused by a specific
enzyme (LTA4 hydrolase) being switched off by the mycotoxin. "This
interrupts communication between the immune cells and destroys the defence
mechanism. As a result, it is easy for spores – in this case the fungus – that
enter the organism to infiltrate tissues or organs," says Werz.
Cooperation in Cluster of Excellence “Balance of the
Microverse”
For their study, Prof. Werz and his colleagues collaborated with
researchers from the Leibniz Institute for Natural Product Research and
Infection Biology (Hans Knöll Institute). As part of the Collaborative Research
Centre "ChemBioSys" and the Jena Cluster of Excellence "Balance
of the Microverse", they cooperated with the working groups led by Prof.
Axel Brakhage and Prof. Christian Hertweck, which contributed their expertise
in mycology and natural product synthesis. Additional partners are research
groups from the Universities of Frankfurt and Naples ,
as well as the Karolinska Institute in Stockholm .
No comments:
Post a Comment